Molecules / Eprosartan

Eprosartan API manufacturers

CAS 133040-01-4 ATC C09CA02 · Angiotensin II receptor blockers Updated 9 July 2026
5
manufacturers with an active filing 5 of them hold a US DMF or a CEP
14
shortage records on file across 2 countries
44
finished-dose makers across 18 regulators
Showing 5 of 5 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Hetero

India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for eprosartan, filing since 2009. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.

US DMF
2 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
6 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
02

Dishman Carbogen Amcis

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for eprosartan, filing since 2005. Its 2025 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Glochem Industries

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for eprosartan, filing since 2010. Its 2024 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Jubilant Biosys

India
Makes the API

Holds 2 active US DMFs for eprosartan, filing since 2009. Its 2022 FDA inspection closed as VAI.

US DMF
2 active
CEP
None on file
Last FDA inspection
2022 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
05

Zhejiang Huahai Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for eprosartan, filing since 2012. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · OAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile

2 more manufacturers hold filings for eprosartan

The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.

Jubilant BiosysZhejiang Huahai Pharmaceutical
Chat with Fred, your AI analyst

Finished-dose makers (4)

Viatris United States Abbvie United States Công ty cổ phần dược phẩm SaVi Vietnam Hochster Pharmaceutical Industries Egypt

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Who makes eprosartan?

Ask Fred which manufacturers are on record for eprosartan and what filings they hold.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Also on this molecule

Shortages 14 Finished dose 4 Contract mfrs 0